Phenotypic screening reveals TNFR2 as a promising target for cancer immunotherapy

por Williams, Geoffrey S., Mistry, Bina, Guillard, Sandrine, Ulrichsen, Jane Coates, Sandercock, Alan M., Wang, Jun, González-Muñoz, Andrea, Parmentier, Julie, Black, Chelsea, Soden, Jo, Freeth, Jim, Jovanović, Jelena, Leyland, Rebecca, Al-Lamki, Rafia S., Leishman, Andrew J., Rust, Steven J., Stewart, Ross, Jermutus, Lutz, Bradley, John R., Bedian, Vahe, Valge-Archer, Viia, Minter, Ralph, Wilkinson, Robert W.
Publicado en Oncotarget (2016)